Weaver Capital Management LLC Acquires 85 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Weaver Capital Management LLC increased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 3.9% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,265 shares of the company’s stock after buying an additional 85 shares during the quarter. Weaver Capital Management LLC’s holdings in HCA Healthcare were worth $728,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. boosted its holdings in HCA Healthcare by 0.4% during the first quarter. Vanguard Group Inc. now owns 16,989,683 shares of the company’s stock valued at $5,666,569,000 after purchasing an additional 60,304 shares in the last quarter. Sanders Capital LLC boosted its holdings in HCA Healthcare by 4.2% during the fourth quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock valued at $3,086,836,000 after purchasing an additional 456,738 shares in the last quarter. Wellington Management Group LLP boosted its holdings in HCA Healthcare by 1.7% during the fourth quarter. Wellington Management Group LLP now owns 10,186,129 shares of the company’s stock valued at $2,757,181,000 after purchasing an additional 170,560 shares in the last quarter. Royal Bank of Canada boosted its holdings in HCA Healthcare by 35.7% during the fourth quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock valued at $1,219,121,000 after purchasing an additional 1,183,890 shares in the last quarter. Finally, Capital World Investors boosted its holdings in shares of HCA Healthcare by 57.5% in the 1st quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock worth $931,342,000 after acquiring an additional 1,019,750 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at HCA Healthcare

In other news, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at approximately $6,303,912.75. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other HCA Healthcare news, SVP Kathleen M. Whalen sold 2,987 shares of the stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total value of $1,085,804.37. Following the transaction, the senior vice president now directly owns 9,454 shares of the company’s stock, valued at approximately $3,436,623.54. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at $6,303,912.75. The disclosure for this sale can be found here. Insiders sold a total of 8,844 shares of company stock worth $3,185,932 in the last three months. Insiders own 1.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. Deutsche Bank Aktiengesellschaft boosted their target price on HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a report on Friday, June 28th. Royal Bank of Canada boosted their target price on HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a report on Friday, August 23rd. UBS Group boosted their target price on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a report on Wednesday, August 14th. Robert W. Baird assumed coverage on shares of HCA Healthcare in a research report on Thursday, May 30th. They issued an “outperform” rating and a $396.00 price objective for the company. Finally, Truist Financial boosted their price objective on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, August 19th. Five equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $359.89.

HCA Healthcare Price Performance

Shares of HCA stock opened at $395.83 on Wednesday. The firm has a market capitalization of $103.67 billion, a price-to-earnings ratio of 19.74, a price-to-earnings-growth ratio of 1.52 and a beta of 1.68. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. HCA Healthcare, Inc. has a 12-month low of $215.96 and a 12-month high of $397.73. The firm has a fifty day moving average of $351.93 and a 200-day moving average of $334.46.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. The firm had revenue of $17.49 billion during the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The company’s revenue for the quarter was up 10.3% compared to the same quarter last year. During the same period in the prior year, the business earned $4.29 EPS. On average, equities research analysts forecast that HCA Healthcare, Inc. will post 22.5 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be paid a dividend of $0.66 per share. The ex-dividend date is Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.67%. HCA Healthcare’s dividend payout ratio is 13.16%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.